Two commonly used psychiatric drugs show evidence of improving symptoms of Alzheimer's disease including boosting cognition, according to a study from researchers at the University of Colorado Anschutz Medical Campus.
Jun 29, 2022
0
54
Lamivudine, a commonly-used antiretroviral drug for treating HIV, improves cognition in a mouse model of Down syndrome, according to the findings of a joint new study by researchers at the Centre for Genomic Regulation (CRG) ...
Jun 28, 2022
0
11
La Trobe University-led research may have uncovered the cause of the neurological conditions seen in patients with long COVID, such as brain fog.
Jun 16, 2022
0
132
Inside the body, some seemingly harmless proteins have sinister potential. In the case of Alzheimer's disease, the amyloid-beta (Aβ) protein, which is vital for brain growth, can become tainted and destroy cells, which leads ...
Jun 14, 2022
0
34
A simple blood test to diagnose Alzheimer's disease, perhaps even years before symptoms appear, is an exciting possibility, but a new study shows that much more research is needed before these blood tests are routinely used ...
May 26, 2022
0
39
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer's disease.
May 25, 2022
0
445
In patients with serious and long-term COVID-19, disturbed blood coagulation has often been observed. Now, researchers at Linköping University (LiU), Sweden, have discovered that the body's immune system can affect the spike ...
May 19, 2022
0
760
QUT genetic researchers have found blood proteins that cause migraine and have a shared link with Alzheimer's disease that could potentially be prevented by repurposing existing therapeutics.
May 12, 2022
0
82
The U.S. Food and Drug Administration granted marketing approval for the Lumipulse G β-Amyloid Ratio (1-42/1-40) test, the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer disease, ...
May 09, 2022
0
5
During experiments in animal models, researchers at the University of Kansas have discovered a possible new approach to immunization against Alzheimer's disease (AD).
May 03, 2022
0
114
